The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brain Cancer Targeted Drug Market Research Report 2025
Synopsis
A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist.
The global Brain Cancer Targeted Drug market was valued at US$ 1248 million in 2023 and is anticipated to reach US$ 2326.4 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Targeted Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Targeted Drug.
Report Scope
The Brain Cancer Targeted Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Cancer Targeted Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Targeted Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Roche
Novartis
Segment by Type
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Targeted Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist.
The global Brain Cancer Targeted Drug market was valued at US$ 1248 million in 2023 and is anticipated to reach US$ 2326.4 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Targeted Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Targeted Drug.
Report Scope
The Brain Cancer Targeted Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Cancer Targeted Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Targeted Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Roche
Novartis
Segment by Type
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Targeted Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Targeted Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Belzutifan (Welireg)
1.2.3 Bevacizumab (Avastin)
1.2.4 Everolimus (Afinitor)
1.3 Market by Application
1.3.1 Global Brain Cancer Targeted Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Targeted Drug Market Perspective (2019-2030)
2.2 Brain Cancer Targeted Drug Growth Trends by Region
2.2.1 Global Brain Cancer Targeted Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Cancer Targeted Drug Historic Market Size by Region (2019-2024)
2.2.3 Brain Cancer Targeted Drug Forecasted Market Size by Region (2025-2030)
2.3 Brain Cancer Targeted Drug Market Dynamics
2.3.1 Brain Cancer Targeted Drug Industry Trends
2.3.2 Brain Cancer Targeted Drug Market Drivers
2.3.3 Brain Cancer Targeted Drug Market Challenges
2.3.4 Brain Cancer Targeted Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Targeted Drug Players by Revenue
3.1.1 Global Top Brain Cancer Targeted Drug Players by Revenue (2019-2024)
3.1.2 Global Brain Cancer Targeted Drug Revenue Market Share by Players (2019-2024)
3.2 Global Brain Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Targeted Drug Revenue
3.4 Global Brain Cancer Targeted Drug Market Concentration Ratio
3.4.1 Global Brain Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Targeted Drug Revenue in 2023
3.5 Brain Cancer Targeted Drug Key Players Head office and Area Served
3.6 Key Players Brain Cancer Targeted Drug Product Solution and Service
3.7 Date of Enter into Brain Cancer Targeted Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Targeted Drug Breakdown Data by Type
4.1 Global Brain Cancer Targeted Drug Historic Market Size by Type (2019-2024)
4.2 Global Brain Cancer Targeted Drug Forecasted Market Size by Type (2025-2030)
5 Brain Cancer Targeted Drug Breakdown Data by Application
5.1 Global Brain Cancer Targeted Drug Historic Market Size by Application (2019-2024)
5.2 Global Brain Cancer Targeted Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Cancer Targeted Drug Market Size (2019-2030)
6.2 North America Brain Cancer Targeted Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Cancer Targeted Drug Market Size by Country (2019-2024)
6.4 North America Brain Cancer Targeted Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Targeted Drug Market Size (2019-2030)
7.2 Europe Brain Cancer Targeted Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Cancer Targeted Drug Market Size by Country (2019-2024)
7.4 Europe Brain Cancer Targeted Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Targeted Drug Market Size (2019-2030)
8.2 Asia-Pacific Brain Cancer Targeted Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Targeted Drug Market Size (2019-2030)
9.2 Latin America Brain Cancer Targeted Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Cancer Targeted Drug Market Size by Country (2019-2024)
9.4 Latin America Brain Cancer Targeted Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Targeted Drug Market Size (2019-2030)
10.2 Middle East & Africa Brain Cancer Targeted Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Detail
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Brain Cancer Targeted Drug Introduction
11.1.4 Merck & Co. Revenue in Brain Cancer Targeted Drug Business (2019-2024)
11.1.5 Merck & Co. Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Brain Cancer Targeted Drug Introduction
11.2.4 Roche Revenue in Brain Cancer Targeted Drug Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Brain Cancer Targeted Drug Introduction
11.3.4 Novartis Revenue in Brain Cancer Targeted Drug Business (2019-2024)
11.3.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Brain Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Belzutifan (Welireg)
Table 3. Key Players of Bevacizumab (Avastin)
Table 4. Key Players of Everolimus (Afinitor)
Table 5. Global Brain Cancer Targeted Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Brain Cancer Targeted Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Brain Cancer Targeted Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Brain Cancer Targeted Drug Market Share by Region (2019-2024)
Table 9. Global Brain Cancer Targeted Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Brain Cancer Targeted Drug Market Share by Region (2025-2030)
Table 11. Brain Cancer Targeted Drug Market Trends
Table 12. Brain Cancer Targeted Drug Market Drivers
Table 13. Brain Cancer Targeted Drug Market Challenges
Table 14. Brain Cancer Targeted Drug Market Restraints
Table 15. Global Brain Cancer Targeted Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Brain Cancer Targeted Drug Market Share by Players (2019-2024)
Table 17. Global Top Brain Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Targeted Drug as of 2023)
Table 18. Ranking of Global Top Brain Cancer Targeted Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Brain Cancer Targeted Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Brain Cancer Targeted Drug Product Solution and Service
Table 22. Date of Enter into Brain Cancer Targeted Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Brain Cancer Targeted Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Brain Cancer Targeted Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Brain Cancer Targeted Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Brain Cancer Targeted Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Brain Cancer Targeted Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Brain Cancer Targeted Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Brain Cancer Targeted Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Brain Cancer Targeted Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Brain Cancer Targeted Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Brain Cancer Targeted Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Brain Cancer Targeted Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Brain Cancer Targeted Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Brain Cancer Targeted Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Brain Cancer Targeted Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Brain Cancer Targeted Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck & Co. Company Detail
Table 48. Merck & Co. Business Overview
Table 49. Merck & Co. Brain Cancer Targeted Drug Product
Table 50. Merck & Co. Revenue in Brain Cancer Targeted Drug Business (2019-2024) & (US$ Million)
Table 51. Merck & Co. Recent Development
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Brain Cancer Targeted Drug Product
Table 55. Roche Revenue in Brain Cancer Targeted Drug Business (2019-2024) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Brain Cancer Targeted Drug Product
Table 60. Novartis Revenue in Brain Cancer Targeted Drug Business (2019-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Cancer Targeted Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Brain Cancer Targeted Drug Market Share by Type: 2023 VS 2030
Figure 3. Belzutifan (Welireg) Features
Figure 4. Bevacizumab (Avastin) Features
Figure 5. Everolimus (Afinitor) Features
Figure 6. Global Brain Cancer Targeted Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Brain Cancer Targeted Drug Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Brain Cancer Targeted Drug Report Years Considered
Figure 12. Global Brain Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Brain Cancer Targeted Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Brain Cancer Targeted Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Brain Cancer Targeted Drug Market Share by Players in 2023
Figure 16. Global Top Brain Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Targeted Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Brain Cancer Targeted Drug Revenue in 2023
Figure 18. North America Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Brain Cancer Targeted Drug Market Share by Country (2019-2030)
Figure 20. United States Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Brain Cancer Targeted Drug Market Share by Country (2019-2030)
Figure 24. Germany Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Brain Cancer Targeted Drug Market Share by Region (2019-2030)
Figure 32. China Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Brain Cancer Targeted Drug Market Share by Country (2019-2030)
Figure 40. Mexico Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Brain Cancer Targeted Drug Market Share by Country (2019-2030)
Figure 44. Turkey Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Brain Cancer Targeted Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Merck & Co. Revenue Growth Rate in Brain Cancer Targeted Drug Business (2019-2024)
Figure 47. Roche Revenue Growth Rate in Brain Cancer Targeted Drug Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Brain Cancer Targeted Drug Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
